Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Coronado Biosciences Inc Announces Key Addition To Management Team


Wednesday, 2 Jan 2013 07:30am EST 

Coronado Biosciences Inc announced the appointment of Harlan F. Weisman, M.D., a director for the Company since August 2012, as its new Chairman and Chief Executive Officer (CEO). Bobby W. Sandage, Jr., will continue in his role as President and a member of the Board of Directors. In addition, Glenn L. Cooper, M.D., will step down as Executive Chairman of the board of the Company, although Dr. Cooper will continue to support the company in a consulting role. 

Company Quote

1.83
-0.05 -2.66%
15 Sep 2014